Demant A/S
OTC:WILLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Demant A/S
OTC:WILLF
|
DK |
|
M
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
US |
|
S
|
Sarine Technologies Ltd
TASE:SARN
|
IL |
|
F
|
Filtronic PLC
OTC:FLTCF
|
UK |
|
Novolipetsk Steel PAO
MOEX:NLMK
|
RU |
Earnings Calls
Last Earnings Call
Outlook raised: Demant lifted 2026 organic revenue growth guidance to 6% to 7% and EBIT before special items to DKK 4.4 billion to DKK 4.8 billion after a strong first half and better second-half momentum.
Strong first half: Reported revenue rose 15%, with 7% organic growth and 10% acquisitive growth, led by Hearing Aids, Hearing Care, and Diagnostics.
Margins improved: Gross margin increased by 1.1 percentage points, helped by stronger product and geography mix in Hearing Aids and the KIND acquisition in Hearing Care.
Launch momentum: Oticon Zeal continued to drive strong growth, and Demant said the newly announced Oticon Reveal should further support growth and pricing.
Costs and cash: Cost-saving initiatives are progressing ahead of plan, cash flow was strong, and leverage has already fallen to 3.0, ahead of the company’s deleveraging plan.